Active Ingredient(s): Drospirenone + Estetrol
FDA Approved: * April 15, 2021
Pharm Company: * MAYNE PHARMA
Category: Birth Control / Contraceptive

Drospirenone/estetrol, sold under the brand name Nextstellis among others, is a fixed-dose combination medication containing drospirenone, a progestin, and estetrol, an estrogen, which is used as a combined birth control pill for the prevention of pregnancy in women.[2][4] It is taken by mouth.[2][4] It was approved for medical use in Canada in March 2021,[3] and in the United States in April 2021.[4&#... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

NextstellisNextstellis Kit
NDC: 51862-258
Mayne Pharma